Clover Health Investments, Corp. (CLOV) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 107.89M | -68.15M | 12.1M | 5.41M | -16.29M | -85.83M | 49.99M | 44.76M | 25.93M | -258.09M | -18.78M | 53.17M |
| Operating CF Margin % | 14.5% | -13.97% | 2.44% | 1.13% | -3.52% | -25.47% | 15.1% | 12.56% | 7.48% | -50.58% | -6.14% | 16.61% |
| Operating CF Growth % | 762.22% | 20.6% | -75.79% | -87.92% | -162.82% | 66.74% | 366.15% | -15.83% | -67.18% | -23.27% | -118.48% | 235.75% |
| Net Income | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -22.09M | -9.15M | 7.41M | -19.17M | -70.47M | -41.47M | -28.81M |
| Depreciation & Amortization | 0 | 420K | 406K | 394K | 466K | 344K | 339K | 330K | 318K | 674K | 557K | 999K |
| Stock-Based Compensation | 0 | 24.92M | 26.11M | 26.2M | 26.44M | 29.64M | 27.99M | 27.9M | 28.8M | 33.14M | 33.07M | 36.11M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.16M |
| Other Non-Cash Items | 12.46M | 7.34M | -205K | -1.08M | 61K | -39.62M | -438K | -2.04M | -8.57M | -9.63M | 12.97M | -1.22M |
| Working Capital Changes | 68.1M | -51.51M | 10.17M | -9.53M | -41.98M | -54.11M | 31.25M | 11.16M | 24.55M | -211.79M | -23.91M | 51.26M |
| Change in Receivables | 0 | -38.55M | 27.84M | 6.91M | -45.46M | -36.22M | 68.62M | 35.15M | -74.1M | 32.88M | -197.92M | 73.8M |
| Change in Inventory | - | - | - | - | - | - | - | - | - | - | - | - |
| Change in Payables | 0 | 3.27M | -1.01M | 3.4M | -4.01M | 8.82M | -14.7M | 5.03M | -1.78M | 1.89M | -4.62M | -7.53M |
| Cash from Investing | -5.07M | -34.99M | -5.42M | 35.57M | 8.93M | -1.44M | -12.13M | 4.95M | 9.19M | 83.66M | -20.32M | 66.49M |
| Capital Expenditures | -854K | -597K | -692K | -569K | -185K | -315K | -399K | -397K | -445K | 264K | -243K | -354K |
| CapEx % of Revenue | 0.11% | 0.12% | 0.14% | 0.12% | 0.04% | 0.09% | 0.12% | 0.11% | 0.13% | 0.05% | 0.08% | 0.11% |
| Acquisitions | - | - | - | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66.84M |
| Cash from Financing | -7.86M | -8.61M | -5.27M | -7.76M | -31.74M | -6.14M | -4.67M | -3.19M | -3.36M | -826K | -1.96M | -147K |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | -7.86M | -8.61M | -5.27M | -7.76M | -31.74M | -6.14M | -4.67M | -3.19M | -3.36M | -826K | -1.96M | -147K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -7.89M | -9.2M | -5.58M | -8.47M | -31.96M | -6.8M | -4.89M | -3.22M | -3.36M | -827K | -1.99M | -417K |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 94.96M | -111.75M | 1.41M | 33.21M | -39.1M | -93.41M | 33.19M | 46.52M | 31.76M | -182.61M | -41.06M | 119.52M |
| Free Cash Flow | 107.04M | -68.75M | 11.41M | 4.84M | -16.48M | -86.15M | 49.59M | 44.36M | 25.49M | -257.82M | -19.02M | 52.82M |
| FCF Margin % | 14.38% | -14.1% | 2.3% | 1.01% | -3.56% | -25.57% | 14.98% | 12.45% | 7.35% | -50.53% | -6.22% | 16.5% |
| FCF Growth % | 749.6% | 20.2% | -76.99% | -89.09% | -164.65% | 66.59% | 360.65% | -16.02% | -67.64% | -20.9% | -118.76% | 234.25% |
| FCF per Share | 0.20 | -0.13 | 0.02 | 0.01 | -0.03 | -0.18 | 0.10 | 0.09 | 0.04 | -0.54 | -0.04 | 0.11 |
| FCF Conversion (FCF/Net Income) | 3.95x | 1.38x | -0.50x | -0.51x | 12.79x | 3.89x | -5.46x | 6.04x | -1.35x | 3.66x | 0.45x | -1.85x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |